AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayo-Smith, W. W.
Right arrow Articles by Cronan, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayo-Smith, W. W.
Right arrow Articles by Cronan, J. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Imaging-Guided Percutaneous Radiofrequency Ablation of Solid Renal Masses: Techniques and Outcomes of 38 Treatment Sessions in 32 Consecutive Patients

William W. Mayo-Smith1, Damian E. Dupuy, Pranay M. Parikh, John A. Pezzullo and John J. Cronan

1 All authors: Department of Diagnostic Imaging, Rhode Island Hospital, Brown Medical School, 593 Eddy St., Providence, RI 02903.



View larger version (171K):

[in a new window]
 
Fig. 1A. 79-year-old woman with biopsy-proven renal cell carcinoma of right kidney. Contrast-enhanced CT scan obtained before treatment shows enhancing exophytic mass (arrow) along posterior medial border of right kidney.

 


View larger version (165K):

[in a new window]
 
Fig. 1B. 79-year-old woman with biopsy-proven renal cell carcinoma of right kidney. CT image obtained 2 months after radiofrequency treatment shows decreased size of mass and no enhancement. Note mild dilatation of upper pole calyx (arrow), which is presumably due to heat-induced stricture of collecting system.

 


View larger version (125K):

[in a new window]
 
Fig. 2A. 68-year-old man with solid enhancing mass in left kidney. Contrast-enhanced CT scan obtained before treatment shows enhancing exophytic mass (arrow) in lateral left kidney.

 


View larger version (155K):

[in a new window]
 
Fig. 2B. 68-year-old man with solid enhancing mass in left kidney. CT fluoroscopic image obtained during treatment shows cluster electrode (arrow) along medial aspect of mass. Patient required three separate 6-min treatments of mass at separate locations during treatment session to cause complete necrosis.

 


View larger version (122K):

[in a new window]
 
Fig. 2C. 68-year-old man with solid enhancing mass in left kidney. Contrast-enhanced CT scan obtained 1 month after radiofrequency treatment shows complete tumor necrosis with no enhancement.

 


View larger version (161K):

[in a new window]
 
Fig. 3A. 74-year-old woman with biopsy-proven renal cell carcinoma requiring two radiofrequency treatments. Contrast-enhanced CT scan obtained before treatment shows enhancing exophytic mass (arrow) in posterior lower pole of right kidney.

 


View larger version (136K):

[in a new window]
 
Fig. 3B. 74-year-old woman with biopsy-proven renal cell carcinoma requiring two radiofrequency treatments. CT fluoroscopic image from first radiofrequency ablation shows single electrode in medial portion of lesion.

 


View larger version (108K):

[in a new window]
 
Fig. 3C. 74-year-old woman with biopsy-proven renal cell carcinoma requiring two radiofrequency treatments. Contrast-enhanced CT scan obtained 2 months after original radiofrequency ablation shows residual enhancing tumor (arrow).

 


View larger version (124K):

[in a new window]
 
Fig. 3D. 74-year-old woman with biopsy-proven renal cell carcinoma requiring two radiofrequency treatments. Contrast-enhanced CT scan obtained 6 months after second radiofrequency treatment shows no residual enhancing tissue at site of tumor (arrow).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Roentgen Ray Society.